TFs	Transcription factors
DBD	DNA-binding domain
TME	Tumor microenvironment
SRY	Sex-determining region Y
HMG	High-mobility group
SOX	Sex-determining region Y-related high-mobility group box
HCC	Hepatocellular carcinoma
TIME	Tumor immune microenvironment
CSCs	Cancer stem cells
TICs	Tumor-initiating cells
EMT	Epithelial-mesenchymal transition
miRNA	MicroRNA
HBV	Hepatitis B virus
SNP	Single-nucleotide polymorphism
3′UTR	3′ untranslated region
AFP	Alpha-fetoprotein
PVTT	Portal vein tumor thrombosis
HSCs	Hepatic stellate cells
MDSCs	Myeloid-derived suppressor cells
IFNI	Type I interferon
APCs	Antigen-presenting cells
DCs	Dendritic cells
STING	Stimulator of interferon genes
Treg	Regulatory T cell
ISG.RS	Interferon-stimulated genes resistance signature
ICIs	Immune checkpoint inhibitors
TANs	Tumor-associated neutrophils
TNBC	Triple-negative breast cancer
TAM	Tumor-associated macrophage
DCreg	Regulatory dendritic cell
Breg	Regulatory B cell
HLA	Human leukocyte antigen
SMO	Smoothened
PROTACs	Proteolysis-targeting chimeras
SAHA	Suberoylanilide hydroxamic acid
CTLs	Cytotoxic T lymphocytes
siRNAs	Small interfering RNAs
NPs	Nanoparticles
CL-siSOX2	siSOX2 delivered by cationic lipoplex
RGDfC-SeNPs	RGDfC-modified functionalized selenium nanoparticles
ATFs	Artificial transcription factors
ZF	Zinc-finger
SRR1	SOX2 regulatory region I
SKD	Kruppel Associated box